Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple SclerosisTim Spelman, Jan Lycke, Melinda Magyari et al.|JAMA Neurology|2021Cited by 237
Initial high-efficacy disease-modifying therapy in multiple sclerosisMathias Due Buron, Melinda Magyari, Thor Ameri Chalmer et al.|Neurology|2020Cited by 160
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in DenmarkViktoria Papp, Thor Petersen, Claudia Pfleger et al.|Neurology|2018Cited by 104
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Vincent Van Pesch, Stella Hughes et al.|JAMA Neurology|2023Cited by 62
Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES)Morten Riemenschneider, Ulrik Dalgas, Lars G. Hvid et al.|Multiple Sclerosis Journal|2022Cited by 48